Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India

References

• Chan JKC, Quintanilla-Martinez L, Ferry JA, et al. Extranodal NK/T cell lymphoma nasal type. In: Swerdlow S, Campo E, Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. pp 285–288.
   Google Scholar
• Vose J, Armitage J, Weisenburger D;International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
   PubMed Web of Science ®Google Scholar
• George LC, Rowe M, Fox CP. Epstein-Barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved. Curr Hematol Malig Rep 2012;7:276–284.
   PubMedGoogle Scholar
• Kanno H, Kojya S, Li T, et al. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. Int J Cancer 2000;87:195–199.
   PubMed Web of Science ®Google Scholar
• Kim TM, Lee SY, Jeon YK, et al.; Lymphoma Subcommittee of the Korean Cancer Study Group. Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 2008;19:1477–1484.
   PubMed Web of Science ®Google Scholar
• Au WY, Weisenburger DD, Intragumtornchai T, et al. Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 2009;113:3931–3937.
   PubMed Web of Science ®Google Scholar
• Li YX, Liu QF, Fang H, et al. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma. Clin Cancer Res 2009;15:2905–2912.
   PubMed Web of Science ®Google Scholar
• Li S, Feng X, Li T, et al. Extranodal NK/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 2013;37:14–23.
   PubMed Web of Science ®Google Scholar
• Bugalia A, Manipadam MT, Nair S. Immunomorphologic profile and Epstein-Barr virus status of a cohort of 35 cases of extranodal natural killer/T-cell lymphoma, nasal type of upper aerodigestive tract from a tertiary care center in South India. Leuk Lymphoma 2013;54:1201–1207.
   PubMed Web of Science ®Google Scholar
• Naresh KN, Agarwal B, Nathwani BN, et al. Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 2000 consecutive cases by a panel of five expert hematopathologists. Leuk Lymphoma 2004;45:1569–1577.
   PubMed Web of Science ®Google Scholar
• Sahni CS, Desai SB. Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000). Leuk Lymphoma 2007;48:122–133.
   PubMed Web of Science ®Google Scholar
• Takahashi E, Ohshima K, Kimura H, et al.; NK-cell Tumor Study Group. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology 2011;59:660–671.
   PubMed Web of Science ®Google Scholar
• Wee J, Nei WL, Yeoh KW, et al. Why are East Asians more susceptible to several infection-associated cancers (carcinomas of the nasopharynx, stomach, liver, adenocarcinoma of the lung, nasal NK/T-cell lymphomas)?Med Hypoth 2012;79:833–842.
   PubMed Web of Science ®Google Scholar
• Au W, Kwong Y, Chan A. Scrotal skin ulcer in a patient with a previous tonsillectomy because of natural killer cell lymphoma. Am J Dermatopathol 1998;20:582–585.
   PubMed Web of Science ®Google Scholar
• Yeh KH, Lien HC, Hsu SM, et al. Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma. Am J Hematol 1999;60:161–63.
   PubMed Web of Science ®Google Scholar
• Liang DN, Yang ZR, Wang WY, et al. Extranodal nasal type natural killer/T-cell lymphoma of testis: report of seven cases with review of literature. Leuk Lymphoma 2012;53:1117–1123.
   PubMed Web of Science ®Google Scholar
• Chuang SS, Chang ST, Lee YH, et al. Prostatic involvement by nasal NK/T cell lymphoma forming lymphoepithelial lesions. J Clin Pathol 2008;61:399–400.
   PubMed Web of Science ®Google Scholar
• Fujiwara H, Maeda Y, Nawa Y, et al. The utility of positron emission tomography/computed tomography in the staging of extranodal natural killer/T-cell lymphoma. Eur J Haematol 2011;87:123–129.
   PubMed Web of Science ®Google Scholar
• Karantanis D, Subramaniam RM, Peller PJ, et al. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma 2008;8:94–99.
   PubMedGoogle Scholar
• Chan WK, Au WY, Wong CY, et al. Metabolic activity measured by F-18 FDG PET in natural killer-cell lymphoma compared to aggressive B- and T-cell lymphomas. Clin Nucl Med 2010;35:571–575.
   PubMed Web of Science ®Google Scholar
• Suh C, Kang YK, Roh JL, et al. Prognostic value of tumor 18F-FDG uptake in patients with untreated extranodal natural killer/T-cell lymphomas of the head and neck. J Nucl Med 2008;49:1783–1789.
   PubMed Web of Science ®Google Scholar
• Berti E, Recalcati S, Girgenti V, et al. Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization. Blood 2010;116:165–170.
   PubMed Web of Science ®Google Scholar
• Hasserjian RP, Harris NL. NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype. Am J Clin Pathol 2007;127:860–868.
   PubMed Web of Science ®Google Scholar
• Nonomura Y, Otsuka A, Endo Y, et al. Extranodal NK/T-cell lymphoma, nasal type, presenting pseudoepitheliomatous hyperplasia mimicking squamous cell carcinoma. Eur J Dermatol 2012;22:688–689.
   PubMed Web of Science ®Google Scholar
• Schwartz EJ, Molina-Kirsch H, Zhao S, et al. Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 2008;130:343–351.
   PubMed Web of Science ®Google Scholar
• Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–618.
   PubMed Web of Science ®Google Scholar
• Xu PP, Wang Y, Shen Y, et al. Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients. Med Oncol 2012;29:2176–2182.
   PubMed Web of Science ®Google Scholar
• Chauchet A, Michallet AS, Berger F, et al. Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma. J Hematol Oncol 2012;5:27.
   PubMed Web of Science ®Google Scholar
• Mitrovic Z, Perry AM, Suzumiya J, et al. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project. Am J Hematol 2012;87:790–794.
   PubMed Web of Science ®Google Scholar
• Huang JJ, Jiang WQ, Lin TY, et al .Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Ann Oncol 2011;22:149–155.
   PubMed Web of Science ®Google Scholar
• Huang WT, Chang KC, Huang GC, et al. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type. Haematologica 2005;90:1063–1069.
   PubMed Web of Science ®Google Scholar
• Lee J, Suh C, Huh J, et alEffect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type. Clin Cancer Res 2007; 13:3250–3254.
   PubMed Web of Science ®Google Scholar
• Sung CO, Ko YH. Bone marrow is involved in less than 10% of patients with nasal-type NK/T cell lymphoma at initial diagnosis. J Korean Med Sci 2004;19:229–233.
   PubMed Web of Science ®Google Scholar
• Wong KF, Chan JK, Cheung MM, et al. Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon. Am J Clin Pathol 2001;115:266–270.
   PubMed Web of Science ®Google Scholar
• Kohrt H, Advani R. Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leuk Lymphoma 2009;50:1773–1784.
   PubMed Web of Science ®Google Scholar
• Li YX, Wang H, Jin J, et al. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma. Int J Radiat Oncol Biol Phys 2012;82:1809–1815.
   PubMed Web of Science ®Google Scholar
• Yong W, Zheng W, Zhang Y. Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Zhonghua Yi Xue Za Zhi 2001;81:773–775.
   PubMedGoogle Scholar
• Jaccard A, Petit B, Girault S, et al. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Ann Oncol 2009;20:110–116.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Kwong YL, Kim WS, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 2011;29:4410–4416.
   PubMed Web of Science ®Google Scholar
• Jaccard A, Gachard N, Marin B, et al.; GELA and GOELAMS Intergroup. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood 2010;117:1834–1839.
   Google Scholar
• Chan A, Tang T, Ng T, et al. To SMILE or not: supportive care matters. J Clin Oncol 2012;30:1015–1016.
   PubMed Web of Science ®Google Scholar